Polarityte (COOL) vs. Its Peers Financial Survey
Polarityte (NASDAQ: COOL) is one of 192 publicly-traded companies in the “Prepackaged software” industry, but how does it contrast to its competitors? We will compare Polarityte to related companies based on the strength of its profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation.
This table compares Polarityte and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
43.1% of Polarityte shares are held by institutional investors. Comparatively, 58.4% of shares of all “Prepackaged software” companies are held by institutional investors. 43.3% of Polarityte shares are held by insiders. Comparatively, 21.7% of shares of all “Prepackaged software” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Risk and Volatility
Polarityte has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, Polarityte’s competitors have a beta of -19.85, meaning that their average stock price is 2,085% less volatile than the S&P 500.
This is a summary of current ratings and target prices for Polarityte and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Polarityte currently has a consensus price target of $65.00, indicating a potential upside of 275.07%. As a group, “Prepackaged software” companies have a potential upside of 0.73%. Given Polarityte’s stronger consensus rating and higher probable upside, research analysts plainly believe Polarityte is more favorable than its competitors.
Earnings and Valuation
This table compares Polarityte and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Polarityte||$6.69 million||-$130.82 million||-0.65|
|Polarityte Competitors||$1.79 billion||$190.70 million||-2.74|
Polarityte’s competitors have higher revenue and earnings than Polarityte. Polarityte is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Polarityte beats its competitors on 8 of the 13 factors compared.
PolarityTE, Inc. engages in the regenerative medicine and tissue engineering platform. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its products include SkinTE, OsteoTE, AngioTE, MyoTE, CartTe, AdiposeTE, and NeuralTE. The company was founded in 2004 and is headquartered in Salt Lake City, UT.
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.